|
Mullinax said in a statement provided Wednesday by the PGA Tour
he used a medication to treat a condition he was diagnosed with
while in college without seeking approval under the policy.
My lack of knowledge is not an excuse, Mullinax said. It was
my responsibility to know the rules before taking any medication
and I failed to do so. I want to be absolutely clear: I have
never taken any substance with the intention of gaining a
competitive advantage. Anyone who knows me knows how much I
respect this game and the values it represents.
He is believed to be the ninth player suspended since the PGA
Tour began drug testing in 2008, and the first since Byeong Hun
An in October 2023. An used a cough syrup sold over the counter
in South Korea that contained a banned substance.
The tour did not provide circumstances of the positive test.
Mullinax, who finished 150th in the FedEx Cup last year and had
conditional status for 2026, has played only three times in the
spring, one a Korn Ferry Tour event. His last appearance was
April 27 at the Zurich Classic of New Orleans.
He is eligible to return Jan. 16, a week before the 2027 season
begins.
All contents © copyright 2026 Associated Press. All rights reserved
 |
|
